IRIS Accounts Production v24.3.2.46 08398811 director 1.3.23 29.2.24 29.2.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh083988112023-02-28083988112024-02-29083988112023-03-012024-02-29083988112022-02-28083988112022-03-012023-02-28083988112023-02-2808398811ns15:EnglandWales2023-03-012024-02-2908398811ns14:PoundSterling2023-03-012024-02-2908398811ns10:Director12023-03-012024-02-2908398811ns10:PrivateLimitedCompanyLtd2023-03-012024-02-2908398811ns10:SmallEntities2023-03-012024-02-2908398811ns10:AuditExempt-NoAccountantsReport2023-03-012024-02-2908398811ns10:SmallCompaniesRegimeForDirectorsReport2023-03-012024-02-2908398811ns10:SmallCompaniesRegimeForAccounts2023-03-012024-02-2908398811ns10:FullAccounts2023-03-012024-02-290839881112023-03-012024-02-2908398811ns10:RegisteredOffice2023-03-012024-02-2908398811ns5:CurrentFinancialInstruments2024-02-2908398811ns5:CurrentFinancialInstruments2023-02-2808398811ns5:Non-currentFinancialInstruments2024-02-2908398811ns5:Non-currentFinancialInstruments2023-02-2808398811ns5:ShareCapital2024-02-2908398811ns5:ShareCapital2023-02-2808398811ns5:RetainedEarningsAccumulatedLosses2024-02-2908398811ns5:RetainedEarningsAccumulatedLosses2023-02-2808398811ns5:NetGoodwill2023-03-012024-02-2908398811ns5:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2908398811ns5:FurnitureFittings2023-03-012024-02-2908398811ns5:MotorVehicles2023-03-012024-02-2908398811ns5:ComputerEquipment2023-03-012024-02-2908398811ns5:NetGoodwill2023-02-2808398811ns5:NetGoodwill2024-02-2908398811ns5:NetGoodwill2023-02-2808398811ns5:FurnitureFittings2023-02-2808398811ns5:MotorVehicles2023-02-2808398811ns5:ComputerEquipment2023-02-2808398811ns5:FurnitureFittings2024-02-2908398811ns5:MotorVehicles2024-02-2908398811ns5:ComputerEquipment2024-02-2908398811ns5:FurnitureFittings2023-02-2808398811ns5:MotorVehicles2023-02-2808398811ns5:ComputerEquipment2023-02-2808398811ns5:WithinOneYearns5:CurrentFinancialInstruments2024-02-2908398811ns5:WithinOneYearns5:CurrentFinancialInstruments2023-02-28
REGISTERED NUMBER: 08398811 (England and Wales)















Unaudited Financial Statements for the Year Ended 29 February 2024

for

Lawsat Pharm Ltd

Lawsat Pharm Ltd (Registered number: 08398811)

Contents of the Financial Statements
for the Year Ended 29 February 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Lawsat Pharm Ltd

Company Information
for the Year Ended 29 February 2024







DIRECTOR: M T Khan





REGISTERED OFFICE: 14 Marlborough Road
Goring-by-Sea
Worthing
Sussex
BN12 4HA





REGISTERED NUMBER: 08398811 (England and Wales)





ACCOUNTANTS: Xenon Tax
WeWork 30 Churchill Place
Canary Wharf
London
E14 5RE

Lawsat Pharm Ltd (Registered number: 08398811)

Balance Sheet
29 February 2024

29.2.24 28.2.23
Notes £    £   
FIXED ASSETS
Intangible assets 4 4,048,937 4,596,139
Tangible assets 5 155,206 204,342
4,204,143 4,800,481

CURRENT ASSETS
Stocks 6 692,550 568,285
Debtors 7 929,069 992,576
Cash at bank 135,701 173,530
1,757,320 1,734,391
CREDITORS
Amounts falling due within one year 8 (1,228,975 ) (983,572 )
NET CURRENT ASSETS 528,345 750,819
TOTAL ASSETS LESS CURRENT
LIABILITIES

4,732,488

5,551,300

CREDITORS
Amounts falling due after more than one year 9 (4,454,799 ) (4,695,137 )
NET ASSETS 277,689 856,163

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 277,687 856,161
SHAREHOLDERS' FUNDS 277,689 856,163

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 29 February 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 29 February 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Lawsat Pharm Ltd (Registered number: 08398811)

Balance Sheet - continued
29 February 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 18 February 2025 and were signed by:





M T Khan - Director


Lawsat Pharm Ltd (Registered number: 08398811)

Notes to the Financial Statements
for the Year Ended 29 February 2024


1. STATUTORY INFORMATION

Lawsat Pharm Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2013, is being amortised evenly over its estimated useful life of twelve years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on cost
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Lawsat Pharm Ltd (Registered number: 08398811)

Notes to the Financial Statements - continued
for the Year Ended 29 February 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 33 (2023 - 34 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 March 2023
and 29 February 2024 7,571,906
AMORTISATION
At 1 March 2023 2,975,767
Amortisation for year 547,202
At 29 February 2024 3,522,969
NET BOOK VALUE
At 29 February 2024 4,048,937
At 28 February 2023 4,596,139

Lawsat Pharm Ltd (Registered number: 08398811)

Notes to the Financial Statements - continued
for the Year Ended 29 February 2024


5. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 March 2023 346,097 89,353 16,034 451,484
Additions 3,383 - 1,833 5,216
At 29 February 2024 349,480 89,353 17,867 456,700
DEPRECIATION
At 1 March 2023 200,148 34,418 12,576 247,142
Charge for year 39,189 13,562 1,601 54,352
At 29 February 2024 239,337 47,980 14,177 301,494
NET BOOK VALUE
At 29 February 2024 110,143 41,373 3,690 155,206
At 28 February 2023 145,949 54,935 3,458 204,342

6. STOCKS
29.2.24 28.2.23
£    £   
Stocks 692,550 568,285

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
29.2.24 28.2.23
£    £   
Trade debtors 807,617 894,672
Other debtors 121,452 97,904
929,069 992,576

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
29.2.24 28.2.23
£    £   
Bank loans and overdrafts 199,372 -
Trade creditors 971,624 964,187
Taxation and social security 49,966 19,385
Other creditors 8,013 -
1,228,975 983,572

Lawsat Pharm Ltd (Registered number: 08398811)

Notes to the Financial Statements - continued
for the Year Ended 29 February 2024


9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
29.2.24 28.2.23
£    £   
Bank loans 4,139,648 4,341,565
Other creditors 315,151 353,572
4,454,799 4,695,137

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 1,731,654 3,566,765